Found: 181
Select item for more details and to access through your institution.
Guiding Dyslipidemia Treatment: A Population Pharmacokinetic–Pharmacodynamic Framework for Obicetrapib.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 9, p. 1150, doi. 10.1002/jcph.2448
- By:
- Publication type:
- Article
CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis.
- Published in:
- Frontiers in Endocrinology, 2024, p. 01, doi. 10.3389/fendo.2024.1359780
- By:
- Publication type:
- Article
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
- Published in:
- Current Atherosclerosis Reports, 2024, v. 26, n. 2, p. 35, doi. 10.1007/s11883-023-01184-1
- By:
- Publication type:
- Article
Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment.
- Published in:
- European Journal of Preventive Cardiology, 2024, v. 31, n. 3, p. 302, doi. 10.1093/eurjpc/zwad332
- By:
- Publication type:
- Article
Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment.
- Published in:
- European Heart Journal Open, 2023, v. 3, n. 5, p. 1, doi. 10.1093/ehjopen/oead089
- By:
- Publication type:
- Article
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 2, p. 131, doi. 10.1001/jama.2023.9696
- By:
- Publication type:
- Article
Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022).
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01684-5
- By:
- Publication type:
- Article
Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 9417, doi. 10.3390/ijms23169417
- By:
- Publication type:
- Article
Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.892534
- By:
- Publication type:
- Article
A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study.
- Published in:
- Journal of the American Heart Association, 2022, v. 11, n. 6, p. 1, doi. 10.1161/JAHA.121.024176
- By:
- Publication type:
- Article
A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Combination lipid-lowering therapy as first-line strategy in very high-risk patients.
- Published in:
- European Heart Journal, 2022, v. 43, n. 8, p. 830, doi. 10.1093/eurheartj/ehab718
- By:
- Publication type:
- Article
Longitudinal Assessment of Lipoprotein(a) Levels in Perinatally HIV-Infected Children and Adolescents.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 10, p. 2067, doi. 10.3390/v13102067
- By:
- Publication type:
- Article
Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Update on Lipids and Lipoproteins-Reply.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative.
- Published in:
- Liver International, 2020, v. 40, n. 11, p. 2860, doi. 10.1111/liv.14643
- By:
- Publication type:
- Article
Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials.
- Published in:
- Cardiovascular Research, 2020, v. 116, n. 11, p. e136, doi. 10.1093/cvr/cvaa212
- By:
- Publication type:
- Article
Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 9, p. 1, doi. 10.1007/s11883-020-00867-3
- By:
- Publication type:
- Article
Lipids and Lipoproteins in 2020.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical Profiles.
- Published in:
- Journal of the Endocrine Society, 2019, v. 3, n. 12, p. 2397, doi. 10.1210/js.2019-00214
- By:
- Publication type:
- Article
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?
- Published in:
- European Heart Journal, 2018, v. 39, n. 46, p. 4109, doi. 10.1093/eurheartj/ehy723
- By:
- Publication type:
- Article
Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.
- Published in:
- Clinical Cardiology, 2018, v. 41, n. 10, p. 1281, doi. 10.1002/clc.23055
- By:
- Publication type:
- Article
Homozygous familial hypercholesterolaemia: light at the end of the tunnel.
- Published in:
- European Heart Journal, 2018, v. 39, n. 14, p. 1169, doi. 10.1093/eurheartj/ehx438
- By:
- Publication type:
- Article
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Can we afford not to screen for FH?
- Published in:
- European Heart Journal, 2017, v. 38, n. 23, p. 1840, doi. 10.1093/eurheartj/ehx197
- By:
- Publication type:
- Article
Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia.
- Published in:
- European Heart Journal, 2017, v. 38, n. 8, p. 565, doi. 10.1093/eurheartj/ehw135
- By:
- Publication type:
- Article
Time to change the SCORE?
- Published in:
- European Heart Journal, 2017, v. 38, n. 8, p. 595, doi. 10.1093/eurheartj/ehw428
- By:
- Publication type:
- Article
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients.
- Published in:
- JAMA: Journal of the American Medical Association, 2016, v. 316, n. 22, p. 2373, doi. 10.1001/jama.2016.16951
- By:
- Publication type:
- Article
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia.
- Published in:
- Cardiology, 2016, v. 135, n. 1, p. 3, doi. 10.1159/000445047
- By:
- Publication type:
- Article
Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/ kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 study.
- Published in:
- European Heart Journal, 2016, v. 37, n. 17, p. 1360, doi. 10.1093/eurheartj/ehv707
- By:
- Publication type:
- Article
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial.
- Published in:
- American Journal of Cardiovascular Drugs, 2016, v. 16, n. 1, p. 55, doi. 10.1007/s40256-015-0146-z
- By:
- Publication type:
- Article
Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemia.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 1, p. 19, doi. 10.1007/s00228-015-1946-4
- By:
- Publication type:
- Article
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia.
- Published in:
- European Heart Journal, 2015, v. 36, n. 43, p. 2996, doi. 10.1093/eurheartj/ehv370
- By:
- Publication type:
- Article
PCSK9 inhibition: the way forward in the treatment of dyslipidemia.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Increasing the Spatial Resolution of 3T Carotid MRI Has No Beneficial Effect for Plaque Component Measurement Reproducibility.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0130878
- By:
- Publication type:
- Article
Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®).
- Published in:
- Diabetes & Vascular Disease Research, 2015, v. 12, n. 3, p. 164, doi. 10.1177/1479164115570301
- By:
- Publication type:
- Article
Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence.
- Published in:
- Pediatric Drugs, 2015, v. 17, n. 2, p. 159, doi. 10.1007/s40272-014-0116-y
- By:
- Publication type:
- Article
Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 10, p. 1029, doi. 10.1001/jama.2015.1206
- By:
- Publication type:
- Article
Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome.
- Published in:
- European Heart Journal, 2015, v. 36, n. 9, p. 560, doi. 10.1093/eurheartj/ehu058
- By:
- Publication type:
- Article
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial†.
- Published in:
- European Heart Journal, 2014, v. 35, n. 46, p. 3277
- By:
- Publication type:
- Article
Treatment of Low HDL-C Subjects with the CETP Modulator Dalcetrapib Increases Plasma Campesterol Only in Those Without ABCA1 and/or ApoA1 Mutations.
- Published in:
- Lipids, 2014, v. 49, n. 12, p. 1245, doi. 10.1007/s11745-014-3956-x
- By:
- Publication type:
- Article
Prediction of Cardiovascular Events in Statin-Treated Stable Coronary Patients of the Treating to New Targets Randomized Controlled Trial by Lipid and Non-Lipid Biomarkers.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114519
- By:
- Publication type:
- Article
Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial Hypercholesterolemia.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 10, p. 1055, doi. 10.1001/jama.2014.8892
- By:
- Publication type:
- Article
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 3, p. 498, doi. 10.1111/bcp.12380
- By:
- Publication type:
- Article